DK267790D0 - Laegemiddel, der som aktivt stof indeholder svovl-holdige carboxylsyrer, samt midlets anvendelse til bekaempelse af retrovira - Google Patents

Laegemiddel, der som aktivt stof indeholder svovl-holdige carboxylsyrer, samt midlets anvendelse til bekaempelse af retrovira

Info

Publication number
DK267790D0
DK267790D0 DK267790A DK267790A DK267790D0 DK 267790 D0 DK267790 D0 DK 267790D0 DK 267790 A DK267790 A DK 267790A DK 267790 A DK267790 A DK 267790A DK 267790 D0 DK267790 D0 DK 267790D0
Authority
DK
Denmark
Prior art keywords
agent
retrovira
combat
carboxylic acids
per
Prior art date
Application number
DK267790A
Other languages
English (en)
Other versions
DK173585B1 (da
DK267790A (da
Inventor
Joachim Kalden
Bernhard Fleckenstein
Andreas Baur
Thomas Harrer
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of DK267790D0 publication Critical patent/DK267790D0/da
Publication of DK267790A publication Critical patent/DK267790A/da
Priority to DK200001239A priority Critical patent/DK173752B1/da
Application granted granted Critical
Publication of DK173585B1 publication Critical patent/DK173585B1/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
DK199002677A 1989-11-09 1990-11-08 Anvendelse af alfa-liponsyre til fremstilling af et lægemiddel til bekæmpelse af sygdomme fremkaldt af retrovirus DK173585B1 (da)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DK200001239A DK173752B1 (da) 1989-11-09 2000-08-22 Anvendelse af dihydroliponsyre til fremstilling af et lægemiddel til bekæmpelse af sygdomme fremkaldt af retrovirus.

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3937325 1989-11-09
DE3937325 1989-11-09
DE4015728 1990-05-16
DE4015728 1990-05-16

Publications (3)

Publication Number Publication Date
DK267790D0 true DK267790D0 (da) 1990-11-08
DK267790A DK267790A (da) 1991-05-10
DK173585B1 DK173585B1 (da) 2001-04-02

Family

ID=25886910

Family Applications (3)

Application Number Title Priority Date Filing Date
DK199002677A DK173585B1 (da) 1989-11-09 1990-11-08 Anvendelse af alfa-liponsyre til fremstilling af et lægemiddel til bekæmpelse af sygdomme fremkaldt af retrovirus
DK90121339.7T DK0427246T3 (da) 1989-11-09 1990-11-08 Lægemiddel, der som aktivt middel indeholder svovlholdige carboxylsyrer, samt anvendelse deraf til bekæmpelse af retrovira
DK200001239A DK173752B1 (da) 1989-11-09 2000-08-22 Anvendelse af dihydroliponsyre til fremstilling af et lægemiddel til bekæmpelse af sygdomme fremkaldt af retrovirus.

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK90121339.7T DK0427246T3 (da) 1989-11-09 1990-11-08 Lægemiddel, der som aktivt middel indeholder svovlholdige carboxylsyrer, samt anvendelse deraf til bekæmpelse af retrovira
DK200001239A DK173752B1 (da) 1989-11-09 2000-08-22 Anvendelse af dihydroliponsyre til fremstilling af et lægemiddel til bekæmpelse af sygdomme fremkaldt af retrovirus.

Country Status (19)

Country Link
US (1) US5334612A (da)
EP (1) EP0427246B1 (da)
JP (1) JPH03188021A (da)
AT (2) AT500684B8 (da)
BE (2) BE1003834A5 (da)
CA (1) CA2029599C (da)
CH (1) CH684054A5 (da)
DE (3) DE4035456A1 (da)
DK (3) DK173585B1 (da)
ES (2) ES2029769A6 (da)
FR (1) FR2653997B1 (da)
GB (1) GB2239797B (da)
GR (3) GR1001503B (da)
IE (1) IE67874B1 (da)
IT (1) IT1246328B (da)
LU (1) LU87834A1 (da)
NL (1) NL9002438A (da)
PT (1) PT95827B (da)
SE (1) SE508601C2 (da)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2112874T3 (es) * 1991-07-05 1998-04-16 Asta Medica Ag Utilizacion de acidos carboxilicos con contenido en azufre para combatir trastornos de excitacion de origen patofisiologico.
DE4320117A1 (de) * 1992-01-18 1994-12-22 Margarethe Rabien Kombinatinspräparate
DE4201196C2 (de) * 1992-01-18 1997-05-15 Rabien Margarethe Arzneimittel zur Behandlung der Polyneuropathie
ES2111659T3 (es) * 1992-03-11 1998-03-16 Asta Medica Ag Comprimidos, granulados y nodulos con alto contenido en sustancias activas para formas de administracion solidas de alta concentracion.
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE9213914U1 (da) * 1992-10-15 1992-12-03 Asta Medica Ag, 6000 Frankfurt, De
EP0690709A1 (en) * 1993-03-26 1996-01-10 DINU, Constantin Romulus Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
DE4317173C2 (de) * 1993-05-22 1995-06-14 Asta Medica Ag Verwendung von Dihydroliponsäure als Ophthalmologicum
DE4345199C2 (de) * 1993-05-22 1995-10-12 Asta Medica Ag Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
US5463093A (en) * 1993-11-26 1995-10-31 Garnett; Merrill Palladium complexes and methods for using same in the treatment of tumors or Psoriasis
DE4433764A1 (de) 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
DE4439480C1 (de) * 1994-11-08 1996-06-05 Asta Medica Ag Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate
CA2260128A1 (en) * 1996-07-05 1998-01-15 William G. Rice Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
WO1998023606A1 (fr) * 1996-11-27 1998-06-04 Fuji Kagaku Kogyo Kabushiki Kaisha Derives dithio cycliques, remedes contre des maladies renales diabetiques, agents hypoglycemiques, agents hypolipidemiques et agents lenitifs contre les troubles digestifs
US6090842A (en) 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US6197340B1 (en) * 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
AU775388B2 (en) * 1998-11-25 2004-07-29 Yissum Research Development Company Of The Hebrew University Of Jerusalem Scavenger compounds
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
DE10045904B4 (de) * 1999-10-01 2007-07-12 Degussa Gmbh alpha-Liponsäure(-Derivate) enthaltende Retardform
EP1216043B1 (de) * 1999-10-01 2003-05-07 Degussa AG Alpha-liponsäure(-derivate)enthaltende retardform
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
PT1294353E (pt) * 2000-06-06 2006-07-31 Basf Ag Utilizacao do enantiomero (r) do acido lipoico em composicoes cosmeticas e dermatologicas
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
US6683110B1 (en) 2001-05-23 2004-01-27 University Of Central Florida Methyl esters of substituted 4-oxo-2-butenoic acid for treatment of tuberculosis
US6649610B1 (en) 2001-05-23 2003-11-18 University Of Central Florida 2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis
US6852876B1 (en) 2001-06-08 2005-02-08 University Of Central Florida Treatment of colon cancer
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
US6686496B1 (en) 2001-06-08 2004-02-03 University Of Central Florida Treatment of myeloma
WO2003072052A2 (en) * 2002-02-22 2003-09-04 Albany College Of Pharmacy Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
US7030154B2 (en) * 2002-06-07 2006-04-18 Juvenon, Inc. Stability of lipoic acid
DE10229995A1 (de) * 2002-07-03 2004-01-15 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Liponsäure
US20040133938A1 (en) * 2002-11-19 2004-07-08 Yinghui Dan Use of lipoic acid in plant culture media
DE10318045A1 (de) * 2003-04-17 2004-11-04 Basf Ag Stabile Ammoniumsalze der alpha-Liponsäure, ihre Herstellung und Verwendung
JP4716666B2 (ja) * 2003-05-21 2011-07-06 有限会社オガ リサーチ α−リポ酸含有水性製剤
CN100422134C (zh) * 2004-03-12 2008-10-01 北京天衡药物研究院 新的2-（α-正戊酮基）苯甲酸盐及其制法和用途
US20060213815A1 (en) * 2005-01-28 2006-09-28 Wille John J Hydrocarbon fume suppression by higher vapor pressure temperature oils
US20090035403A2 (en) * 2005-06-16 2009-02-05 Mmi Corporation Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof
BRPI0621285A2 (pt) * 2006-01-31 2011-12-06 Parsroos Co método para a preparação de um extrato vegetal e processo de produção de uma composição farmacêutica para estìmulo imunológico e/ou tratamento de infecções por hiv que compreende o referido extrato vegetal
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EA014669B1 (ru) * 2009-06-08 2010-12-30 Общество С Ограниченной Ответственностью "Научно-Производственный Центр Белагроген" Препарат на основе интерферона
US10940206B2 (en) * 2015-05-21 2021-03-09 Ophtalmis Monaco Ophthalmic composition comprising lipoic acid and a mucomimetic polymer

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA901960A (en) * 1972-06-06 Rossler Richard PROCESS FOR STABILIZING .alpha.-LIPOIC ACID IN PHARMACEUTICAL SOLUTIONS
US2840505A (en) * 1954-04-09 1958-06-24 Du Pont Process of treating animals for metal poisoning with thio-compounds
US2875227A (en) * 1955-05-11 1959-02-24 Merck & Co Inc Ephedrine salts of 7-carboethoxy-3-acetylthioheptanoic acid
US2933430A (en) * 1959-01-22 1960-04-19 Du Pont Lipoic acid compositions
DE1617740B1 (de) * 1967-09-25 1971-11-04 Pfrimmer & Co J Verfahren zum Stabilisieren von Alfa-Liponsäure
DE1668887B2 (de) * 1968-03-15 1976-06-16 Ca-salz der 1,2 -dithia-cyclopentan - 3- valerian saeure gleich (thioctsaeure)
ZA716628B (en) * 1970-10-15 1972-06-28 Richardson Merrell Spa Composition and method for treatment of hepatic disease and mental fatigue
JPS5026516A (da) * 1973-07-07 1975-03-19
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
EP0080879B1 (en) * 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Pharmaceutical composition containing interferon in stable state
EP0127012A3 (en) * 1983-05-30 1987-05-27 Suntory Limited Antimutagenic agent and a method of reducing mutagenicity
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
JPS60146829A (ja) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk テストステロン５α−リダクタ−ゼ阻害剤
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
EP0159519A3 (de) * 1984-03-29 1987-02-04 Asta-Werke Aktiengesellschaft Chemische Fabrik Verwendung von Thioverbindungen zur Verhinderung des durch Cytostatika verursachten Haarausfalls
AT390000B (de) * 1985-03-16 1990-02-26 Wellcome Found Verwendung von 3'-azido-3'-desoxythymidin oder eines pharmazeutisch annehmbaren derivats hievon zur herstellung von medikamenten
DE3512911A1 (de) * 1985-04-11 1986-10-16 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von 1,2-dithiolan-3-pentansaeure (thioctsaeure)
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
JP2543096B2 (ja) * 1987-09-24 1996-10-16 松下電器産業株式会社 燃焼装置
ES2038733T3 (es) * 1987-12-04 1993-08-01 Asta Medica Ag Procedimiento para preparar una solucion inyectable de la sal de acido tioctico con trometanol y/o aminoacidos basicos.
DE3840076A1 (de) * 1987-12-04 1989-06-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
JPH01203336A (ja) * 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
IE904034A1 (en) * 1989-11-09 1991-05-22 Asta Medica Ag A medicament containing r-ó-lipoic acid or s-ó-lipoic acid¹as active substance
JPH10203336A (ja) * 1997-01-17 1998-08-04 Aisin Seiki Co Ltd アンチスキッド制御装置

Also Published As

Publication number Publication date
LU87834A1 (de) 1991-05-07
DK0427246T3 (da) 1995-11-27
GR1000918B (el) 1993-03-16
IT9048456A0 (it) 1990-11-08
ATE126053T1 (de) 1995-08-15
IE904035A1 (en) 1991-05-22
AT500684B8 (de) 2006-11-15
GB2239797B (en) 1994-06-15
GR900100796A (en) 1992-04-17
DK173585B1 (da) 2001-04-02
GB2239797A (en) 1991-07-17
BE1003834A5 (fr) 1992-06-23
PT95827A (pt) 1991-09-13
JPH03188021A (ja) 1991-08-16
CA2029599C (en) 1998-08-11
CH684054A5 (de) 1994-07-15
EP0427246A2 (de) 1991-05-15
SE9003564D0 (sv) 1990-11-08
IT9048456A1 (it) 1992-05-08
AT500684B1 (de) 2006-10-15
SE508601C2 (sv) 1998-10-19
SE9003564L (sv) 1991-06-07
DE9017987U1 (de) 1993-12-09
GR1001503B (el) 1994-02-28
EP0427246A3 (en) 1992-06-03
ES2076279T3 (es) 1995-11-01
FR2653997B1 (fr) 1995-01-20
GB9024252D0 (en) 1990-12-19
NL9002438A (nl) 1991-06-03
BE1005018A3 (fr) 1993-03-23
AT500684A1 (de) 2006-02-15
IT1246328B (it) 1994-11-17
DK173752B1 (da) 2001-09-10
IE67874B1 (en) 1996-05-01
DE59009497D1 (de) 1995-09-14
GR3017695T3 (en) 1996-01-31
US5334612A (en) 1994-08-02
PT95827B (pt) 1997-11-28
CA2029599A1 (en) 1991-05-10
EP0427246B1 (de) 1995-08-09
DE4035456A1 (de) 1991-05-16
DK200001239A (da) 2000-08-22
FR2653997A1 (fr) 1991-05-10
ES2029769A6 (es) 1992-09-01
DK267790A (da) 1991-05-10

Similar Documents

Publication Publication Date Title
DK267790A (da) Laegemiddel, der som aktivt stof indeholder svovl-holdige carboxylsyrer, samt midlets anvendelse til bekaempelse af retrovira
KR890016966A (ko) 신규 항바이러스제
ATE228115T1 (de) Bizyklische fibrinogenantagonisten
ATE31537T1 (de) Peptidderivate mit polyzyklischer stickstoffstruktur, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen.
KR890011592A (ko) 기관내 허혈병의 치료용 조성물
GR3026161T3 (en) Use of sulfur containing carboxylic acids for combatting pathophysiologic excitatory disorders
NO923200D0 (no) Piperidin-derivater
ATE19773T1 (de) Nitroaliphatische verbindungen, verfahren zu deren herstellung und deren verwendung.
OA08715A (fr) Nouveaux dérivés peptidiques à structure polyclique azotée, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
TW353658B (en) Substituted tetrahydroisoquinoline compounds, pharmaceutical compositions containing them, and processes for their preparation
ZA933455B (en) Thiochroman compounds, processes for the preparation thereof and pharmaceutical compositions containing them
ZA884276B (en) Tripeptide derivatives having a polycyclic nitrogenous structure,process for the preparation thereof and pharmaceutical compositions containing them
BR9807506A (pt) Derivados de amida e composições medicinais dos mesmos
OA07703A (fr) Polyméthylène imines disubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant.
KR910004192A (ko) 프로페니토인의 치료적 유효량을 함유하는 발작증 치료용 제약 조성물
KR930019683A (ko) 사이클릭 아미노메틸렌 비스포스포네이트 유도체
DE3270406D1 (en) Amidines, process for their preparation, pharmaceutical compounds containing them and their use
IT9048063A1 (it) Composizioni farmaceutiche a base di calcitonina somministrabili per via nasale

Legal Events

Date Code Title Description
PUP Patent expired